A pan-coronavirus peptide inhibitor prevents SARS-CoV-2 infection in mice by intranasal delivery

Coronaviruses (CoVs) have brought serious threats to humans, particularly severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2), which continually evolves into multiple variants. These variants, especially Omicron, reportedly escape therapeutic antibodies and vaccines, indicating an urgent ne...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Science China. Life sciences 2023-10, Vol.66 (10), p.2201-2213
Hauptverfasser:	Wu, Lili, Zheng, Anqi, Tang, Yangming, Chai, Yan, Chen, Jiantao, Cheng, Lin, Hu, Yu, Qu, Jing, Lei, Wenwen, Liu, William Jun, Wu, Guizhen, Zeng, Shaogui, Yang, Hang, Wang, Qihui, Gao, George Fu
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral activity Antiviral agents Biomedical and Life Sciences Coronaviruses Cover Article Intranasal administration Life Sciences Peptide inhibitors Peptides Severe acute respiratory syndrome coronavirus 2
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!